---
id: "20260709-2213-hop-highly-cited-researchers-market"
title: "Clarivate's Highly Cited Researchers list became a market Saudi universities bought into — the exact misuse Garfield warned about"
type: "capture"
status: "promoted"
origin: "hop-batch"
promoted_to: ["30-notes/claim-saudi-universities-bought-clarivate-highly-cited-researcher-status.md (Core claim 1 — HCR credential purchased via paid Saudi affiliations; seedling, audit_status flagged [unverified-quant])","30-notes/claim-garfield-warned-impact-factor-unfit-to-judge-individuals.md (Core claim 2 — Garfield's own warnings against evaluating individuals with the metric; seedling, audit_status flagged [unverified-quote])","30-notes/claim-garfields-isi-became-private-equity-owned-clarivate.md (ISI→Thomson→Clarivate PE-ownership chain, drawn from Hop 1; seedling, capture-verified, uncontested corporate history)"]
questions_routed: ["50-questions/question-verify-clarivate-hcr-saudi-affiliation-counts-and-payments.md (re-verify 27→109→76 counts and ~$72k payment figure against Clarivate's HCR lists and primary reporting)","50-questions/question-verify-garfield-impact-factor-warning-primary-text.md (locate Garfield's archived 2005 talk/essays for the two verbatim quotes now resting on Tier-4 Wikipedia)"]
not_promoted: ["Web of Science's March 2023 delisting of 82 journals (Hop 2) — genuinely distinct but a separate topic (paper-mill enforcement) with all specifics (82, 500+ reviewed, ~20 Hindawi, 24 checks) on Tier-3 sources; left as a lead for its own capture rather than a weak-sourced quant note. Folded as one-line context only.","Elsevier/Scopus as Clarivate's commercial rival (saved hook) — not pursued in the capture; a duopoly-politics thread for a future dedicated capture, noted in the Clarivate-ownership note's commentary.","Private-equity ownership of research infrastructure as its own category (further lead) — noted inside claim-garfields-isi-became-private-equity-owned-clarivate as a saved lead, not a separate note yet."]
model: "claude-sonnet-5"
date_created: "2026-07-09T00:00:00.000Z"
hop_chain: ["seed (Garfield's Science Citation Index -> commercial bibliometrics industry) -> ISI sold to Thomson (1992), spun off to private equity (Onex Corp, Baring Private Equity Asia) as Clarivate in 2016 (max_cosine 0.62)","Clarivate ownership -> Web of Science delisting 82 journals in 2023 for citation cartels/paper mills (max_cosine 0.673)","journal delisting -> Clarivate's 'Highly Cited Researchers' list and King Abdulaziz University's paid-affiliation scheme (max_cosine 0.655)","KAU scandal -> Eugene Garfield's own repeated warnings against using impact factor to evaluate individuals (max_cosine 0.687)"]
novelty_max_cosine: 0.686
tags: ["hop","bibliometrics","science-policy","citation-metrics","clarivate","research-integrity"]
source_url_primary: "https://www.science.org/content/article/saudi-universities-lose-highly-cited-researchers-after-payment-schemes-raise-ethics"
source_tier_primary: 3
source_url_secondary: "https://en.wikipedia.org/wiki/Impact_factor"
source_tier_secondary: 4
source_url_tertiary: "https://en.wikipedia.org/wiki/Clarivate"
source_tier_tertiary: 4
---


## Core claims

**1. Clarivate's "Highly Cited Researchers" (HCR) list became a purchasable credential.** King Abdulaziz University (KAU) and King Saud University offered top-cited foreign scientists cash (reported figures include ~$72,000/year plus business-class travel and hotels) to add KAU as a secondary affiliation, requiring only brief annual visits. The count of HCR-listed researchers with a Saudi affiliation rose from 27 (2014) to 109 (2022), then fell back to 76 after Clarivate tightened affiliation-verification rules. — source_tier: 3 (Science/AAAS news reporting; the underlying HCR count changes are Clarivate's own published lists, not independently re-verified here — flag as [unverified-quant, secondary reporting of a primary count]).

**2. This is precisely the misuse the metric's own inventor warned against.** Eugene Garfield, who created the Journal Impact Factor, said in 2005: "I expected it to be used constructively while recognizing that in the wrong hands it might be abused," and separately warned that impact-factor-style metrics are "an inappropriate and misleading measure of individual research, especially if used for tenure and promotion." — source_tier: 4 (Wikipedia's impact-factor article; the direct quotes trace to Garfield's own 2005 conference remarks, a definitional/biographical claim about settled reception history, acceptable at this tier per sources.md, but a primary Garfield-text citation would strengthen it).

## Why this was hop-worthy

The full arc closes a loop: a tool built to trace scholarly influence (1955) became a business (ISI -> Thomson -> private-equity-owned Clarivate, 2016) that sells a specific numeric credential, which a state actor then bought directly rather than earned — while the tool's own inventor had already named this exact failure mode decades earlier.

## Further leads

- Clarivate's ownership itself (Onex Corporation + Baring Private Equity Asia, now NYSE: CLVT) — the "who profits from ranking science" angle wasn't pursued past the corporate-history level; worth a dedicated capture on PE-owned research infrastructure.
- Elsevier's Scopus as the rival commercial index (est. 2004) — not explored; a Clarivate-vs-Elsevier "duopoly politics" thread is available.
- The sibling captures `2026-07-09-hop-coercive-citation-dora` and `2026-07-09-hop-hirsch-h-index-dias-superconductor-fraud` cover the same seed's Shepard's Citations / Goodhart's Law / h-index branches — this capture deliberately takes the commercial-industry/nation-state-gaming branch to avoid overlap.

> [!note] Seek's commentary:
> The Saudi case is more damning than ordinary citation-stacking because nobody even pretended the metric still meant anything — it became a line item. Garfield spent his life arguing a citation count wasn't a person's worth; a government just paid to make the arithmetic agree anyway.

## Hop chain

Hop 1: "The History of ISI and the work of Eugene Garfield" (Clarivate) / "Clarivate" — Wikipedia — https://clarivate.com/academia-government/the-institute-for-scientific-information/history/ ; https://en.wikipedia.org/wiki/Clarivate
- Hook type: The person behind the thing / cross-domain bridge (academia + private equity)
- Hook: ISI, Garfield's own company, was acquired by Thomson (1992), became Thomson Reuters IP & Science, then was sold in 2016 to private-equity firms Onex Corp and Baring Private Equity Asia and rebranded Clarivate.
- Why followed: Direct answer to the seed's redirect toward the commercial industry — the ownership chain is the "politics" layer.
- Key findings: A scholarly-infrastructure company that started as one man's index now sits inside a public, PE-originated holding company (NYSE: CLVT) alongside EndNote and Journal Citation Reports.

Hop 2: "Web of Science de-listed 82 journals" coverage (Chemistry World, Retraction Watch, Science/AAAS) — https://www.chemistryworld.com/news/how-clarivate-is-clamping-down-on-bad-actors-in-academic-publishing/4021494.article
- Hook type: Mechanism question
- Hook: Clarivate delisted 82 journals from Web of Science in March 2023 (after reviewing 500+) for citation cartels, paper mills, and inappropriate self-citation, affecting Hindawi, Taylor & Francis, and others.
- Why followed: Concrete mechanism of how a commercial gatekeeper polices (and profits from) scientific legitimacy today.
- Key findings: Nearly 20 Hindawi journals delisted specifically for paper-mill activity; the delisting criteria run to 24 quality checks.

Hop 3: "Saudi universities lose highly cited researchers after payment schemes raise ethics concerns" — Science/AAAS — https://www.science.org/content/article/saudi-universities-lose-highly-cited-researchers-after-payment-schemes-raise-ethics
- Hook type: Surprising claim / cross-domain bridge (bibliometrics + Gulf-state soft-power spending)
- Hook: KAU paid top-cited scientists real cash for a secondary affiliation, directly buying rank on Clarivate's flagship reputational product.
- Why followed: The most concrete, quantified instance of the industry's metric being purchased rather than earned — strongest "surprising claim" of the chain.
- Key findings: HCR-affiliated researcher count at KAU/KSU rose from 27 to 109 (2014-2022) then dropped to 76 after Clarivate's 2023 rule tightening on affiliation verification.

Hop 4: "Impact factor" — Wikipedia (summarizing Garfield's own statements) — https://en.wikipedia.org/wiki/Impact_factor
- Hook type: The person behind the thing (closing the loop on the seed's original figure)
- Hook: Garfield explicitly and repeatedly warned that his own metric shouldn't be used to judge individuals, anticipating the exact misuse found in Hop 3.
- Why followed: Zoom-out close: returns to the founder after three hops into the commercial/political mechanism, completing the alternation.
- Key findings: 2005 conference quote ("in the wrong hands it might be abused") plus a documented pattern of Garfield warnings against tenure/promotion use of impact-factor-style metrics.

Saved hooks not followed:
- Elsevier/Scopus as Clarivate's commercial rival — from Hop 1 — a genuine duopoly-politics thread, saved to avoid a 5th zoom-out hop diluting this chain's focus.
- Web of Science's paywalled access model (noted directly in the vault's own `claim-linnainmaa-1976-citation-histogram` as "Web of Science remains unpulled — no access") — from Hop 1 — a strong existing-note connection, saved because pursuing it would have meant re-opening an already-active vault thread rather than extending the hop.
- Private-equity ownership of research infrastructure as its own category (Clarivate is not unique) — from Hop 1 — worth a dedicated future capture.

post-worthy: maybe — well-sourced and closes a satisfying loop (inventor's warning -> industry's product -> state's purchase), but the individual facts (KAU scandal, Garfield's warnings) are each already fairly well-documented rather than newly surprising.